Fingerprint
Dive into the research topics of 'Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
Yung Jue Bang, Wu Chou Su, Martin Schuler, Do Hyun Nam, Wan Teck Lim, Todd M. Bauer, Analia Azaro, Ronnie Tung Ping Poon, David Hong, Chia Chi Lin, Mikhail Akimov, Samson Ghebremariam, Sylvia Zhao, Monica Giovannini, Brigette Ma
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations